Bluma Brenner

8.0k total citations · 1 hit paper
143 papers, 5.0k citations indexed

About

Bluma Brenner is a scholar working on Virology, Infectious Diseases and Molecular Biology. According to data from OpenAlex, Bluma Brenner has authored 143 papers receiving a total of 5.0k indexed citations (citations by other indexed papers that have themselves been cited), including 122 papers in Virology, 116 papers in Infectious Diseases and 30 papers in Molecular Biology. Recurrent topics in Bluma Brenner's work include HIV Research and Treatment (122 papers), HIV/AIDS drug development and treatment (101 papers) and HIV/AIDS Research and Interventions (74 papers). Bluma Brenner is often cited by papers focused on HIV Research and Treatment (122 papers), HIV/AIDS drug development and treatment (101 papers) and HIV/AIDS Research and Interventions (74 papers). Bluma Brenner collaborates with scholars based in Canada, United States and Botswana. Bluma Brenner's co-authors include Mark A. Wainberg, Maureen Oliveira, Daniela Moïsi, Michel Roger, Jean‐Pierre Routy, Michel Ntemgwa, Dan Turner, Yudong Quan, Thibault Mésplède and Dimitrios Coutsinos and has published in prestigious journals such as New England Journal of Medicine, The Lancet and PLoS ONE.

In The Last Decade

Bluma Brenner

143 papers receiving 4.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

High Rates of Forward Transmission Events after Acute/Early HIV‐1 Infection

2007 501 citations Bluma Brenner, Michel Roger et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Bluma Brenner Canada	37	4.2k	4.1k	1.1k	676	354	143	5.0k
Jeannette M. Whitcomb United States	32	3.4k 0.8×	3.7k 0.9×	758 0.7×	1.1k 1.6×	471 1.3×	57	4.8k
Saladin Osmanov Switzerland	27	2.2k 0.5×	2.7k 0.7×	769 0.7×	538 0.8×	482 1.4×	56	3.2k
Neil Parkin United States	41	4.6k 1.1×	4.4k 1.1×	1.0k 0.9×	1.2k 1.8×	310 0.9×	132	6.1k
Katrien Fransen Belgium	32	2.4k 0.6×	2.3k 0.6×	1.0k 0.9×	311 0.5×	262 0.7×	118	3.3k
Horacio Salomón Argentina	31	2.3k 0.5×	2.4k 0.6×	893 0.8×	525 0.8×	476 1.3×	128	3.5k
Nicholas S. Hellmann United States	34	4.1k 1.0×	3.7k 0.9×	737 0.7×	250 0.4×	156 0.4×	49	4.5k
Eric J. Arts United States	47	4.3k 1.0×	4.9k 1.2×	1.1k 1.0×	1.6k 2.4×	985 2.8×	160	6.4k
Michael S Saag United States	13	2.5k 0.6×	2.6k 0.6×	1.1k 1.0×	345 0.5×	780 2.2×	24	3.8k
Lisa M. Demeter United States	34	4.7k 1.1×	4.4k 1.1×	1.3k 1.2×	544 0.8×	378 1.1×	84	6.1k
Miguel E. Quiñones‐Mateu United States	34	2.4k 0.6×	2.5k 0.6×	784 0.7×	707 1.0×	568 1.6×	110	3.7k

Countries citing papers authored by Bluma Brenner

Since Specialization

Citations

This map shows the geographic impact of Bluma Brenner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bluma Brenner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bluma Brenner more than expected).

Fields of papers citing papers by Bluma Brenner

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bluma Brenner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bluma Brenner. The network helps show where Bluma Brenner may publish in the future.

Co-authorship network of co-authors of Bluma Brenner

This figure shows the co-authorship network connecting the top 25 collaborators of Bluma Brenner. A scholar is included among the top collaborators of Bluma Brenner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bluma Brenner. Bluma Brenner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Brenner, Bluma, Ruxandra-Ilinca Ibanescu, Nathan Osman, et al.. (2021). The Role of Phylogenetics in Unravelling Patterns of HIV Transmission towards Epidemic Control: The Quebec Experience (2002–2020). Viruses. 13(8). 1643–1643. 13 indexed citations

Brenner, Bluma. (2020). Phylogenetics: an added ingredient in HIV prevention. AIDS. 34(8). 1247–1248. 1 indexed citations

Oliveira, Maureen, Ruxandra-Ilinca Ibanescu, Kaitlin Anstett, et al.. (2018). Selective resistance profiles emerging in patient-derived clinical isolates with cabotegravir, bictegravir, dolutegravir, and elvitegravir. Retrovirology. 15(1). 56–56. 78 indexed citations

Osman, Nathan, Thibault Mésplède, Maureen Oliveira, et al.. (2018). Durable suppression of HIV-1 with resistance mutations to integrase inhibitors by dolutegravir following drug washout. AIDS. 32(13). 1773–1780. 1 indexed citations

Moodie, Erica E. M., et al.. (2017). Correcting covariate‐dependent measurement error with non‐zero mean. Statistics in Medicine. 36(17). 2786–2800. 3 indexed citations

Palanisamy, Navaneethan, Nathan Osman, Hongtao Xu, et al.. (2017). Does antiretroviral treatment change HIV-1 codon usage patterns in its genes: a preliminary bioinformatics study. AIDS Research and Therapy. 14(1). 2–2. 11 indexed citations

Mésplède, Thibault, Peter K. Quashie, Maureen Oliveira, et al.. (2015). HIV-1 Group O Resistance Against Integrase Inhibitors. JAIDS Journal of Acquired Immune Deficiency Syndromes. 70(1). 9–15. 12 indexed citations

Oliveira, Maureen, Thibault Mésplède, Daniela Moïsi, et al.. (2015). The dolutegravir R263K resistance mutation in HIV-1 integrase is incompatible with the emergence of resistance against raltegravir. AIDS. 29(17). 2255–2260. 11 indexed citations

Alam, Shah Jamal, Ethan Romero-Severson, Christopher J. Henry, et al.. (2012). Detectable signals of episodic risk effects on acute HIV transmission: Strategies for analyzing transmission systems using genetic data. Epidemics. 5(1). 44–55. 13 indexed citations

10.

Coutsinos, Dimitrios, Cédric Invernizzi, Daniela Moïsi, et al.. (2011). A Template-Dependent Dislocation Mechanism Potentiates K65R Reverse Transcriptase Mutation Development in Subtype C Variants of HIV-1. PLoS ONE. 6(5). e20208–e20208. 36 indexed citations

11.

Ntemgwa, Michel, M. John Gill, Bluma Brenner, Daniela Moïsi, & Mark A. Wainberg. (2008). Discrepancies in Assignment of Subtype/Recombinant Forms by Genotyping Programs for HIV Type 1 Drug Resistance Testing May Falsely Predict Superinfection. AIDS Research and Human Retroviruses. 24(7). 995–1002. 11 indexed citations

12.

Ntemgwa, Michel, Thomas d’Aquin Toni, Bluma Brenner, et al.. (2008). Near Full-Length Genomic Analysis of a Novel Subtype A1/C Recombinant HIV Type 1 Isolate from Canada. AIDS Research and Human Retroviruses. 24(4). 655–659. 3 indexed citations

13.

Brenner, Bluma. (2007). Resistance and viral subtypes: how important are the differences and why do they occur?. Current Opinion in HIV and AIDS. 2(2). 94–102. 30 indexed citations

14.

Turner, Dan, Bluma Brenner, Daniela Moïsi, Chen Liang, & Mark A. Wainberg. (2005). Substitutions in the Reverse Transcriptase and Protease Genes of HIV‐1 Subtype B in Untreated Individuals and Patients Treated With Antiretroviral Drugs. Journal of the International AIDS Society. 7(1). 69–69. 4 indexed citations

15.

Doualla‐Bell, Florence, Dan Turner, Hugues Loemba, et al.. (2004). Résistance du VIH aux antirétroviraux : Conséquences pour les pays à faibles revenus. médecine/sciences. 20(10). 882–886. 2 indexed citations

16.

Doualla‐Bell, Florence, Dan Turner, Hugues Loemba, et al.. (2004). Résistance du VIH aux antirétroviraux. médecine/sciences. 20(10). 882–886. 6 indexed citations

17.

Quan, Yudong, Bluma Brenner, Richard Marlink, et al.. (2003). Drug Resistance Profiles of Recombinant Reverse Transcriptases from Human Immunodeficiency Virus Type 1 Subtypes A/E, B, and C. AIDS Research and Human Retroviruses. 19(9). 743–753. 33 indexed citations

18.

Brenner, Bluma, M A Wainberg, & Dan Turner. (2002). HIV-1 drug resistance: can we overcome?. Expert Opinion on Biological Therapy. 2(7). 751–761. 37 indexed citations

19.

Petrella, Marco, Bluma Brenner, Hugues Loemba, & Mark A. Wainberg. (2001). HIV drug resistance and implications for the introduction of antiretroviral therapy in resource-poor countries. Drug Resistance Updates. 4(6). 339–346. 19 indexed citations

20.

Brenner, Bluma & Mark A. Wainberg. (1999). Heat Shock Protein–Based Therapeutic Strategies Against Human Immunodeficiency Virus Type Infection. Infectious Diseases in Obstetrics and Gynecology. 7(1-2). 80–90. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact